DL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Combler les lacunes dans les tests de dépistage de l'hépatite | Bulletin des médecins suisses | 2018 | 473 | 192 | |||
| Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? | PLOS ONE | 2018 | 426 | 203 | |||
| Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 | Swiss Medical Weekly | 2017 | 939 | 236 | |||
| Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland | PloS one | 2015 | 618 | 1,359 | |||
| Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland | Schweizerische medizinische Wochenschrift | 2015 | 612 | 247 | |||
| Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C | PloS one | 2015 | 727 | 368 | |||
| Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection | Schweizerische medizinische Wochenschrift | 2013 | 675 | 0 | |||
| Vaccine safety controversies and the future of vaccination programs | The Pediatric infectious disease journal | 2005 | 637 | 0 | |||
| FluNet as a tool for global monitoring of influenza on the Web | JAMA | 1998 | 705 | 0 |
